RHÖN-KLINIKUM AG

XETRA RHK.DE

RHÖN-KLINIKUM AG Return on Equity (ROE) for the year ending December 31, 2023: 3.09%

RHÖN-KLINIKUM AG Return on Equity (ROE) is 3.09% for the year ending December 31, 2023, a 50.49% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

RHÖN-KLINIKUM AG Return on Equity (ROE) for the year ending December 31, 2022 was 2.05%, a -12.99% change year over year.
RHÖN-KLINIKUM AG Return on Equity (ROE) for the year ending December 31, 2021 was 2.36%, a 1,017.18% change year over year.
RHÖN-KLINIKUM AG Return on Equity (ROE) for the year ending December 31, 2020 was 0.21%, a -94.33% change year over year.
RHÖN-KLINIKUM AG Return on Equity (ROE) for the year ending December 31, 2019 was 3.73%, a -13.66% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

XETRA: RHK.DE

RHÖN-KLINIKUM AG

CEO	Dr. Tobias Kaltenbach
IPO Date	Nov. 25, 1998
Location	Germany
Headquarters	Salzburger Leite 1
Employees	18,507
Sector	Healthcare
Industries Hospitals & Clinics Dental Care

Description

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.

Key trends

Past 5 years